DCF Calculator for Value Stocks
TL;DR
Value-stock DCFs reward discipline. Start with normalized mid-cycle FCF(average over a full cycle), use a low growth rate of 0-5%, apply a 7-10% WACC appropriate for stable businesses, and a terminal growth of 1.5-2.5%. Then require a 25-40% margin of safety before drawing any research conclusion. For conglomerates (BRK.B), use sum-of-the-parts.
Why a value-stock DCF works so well
Value investing and discounted cash flow analysis share the same foundational idea: a business is worth the present value of all the cash it will generate over its lifetime. For value stocks — mature, often unglamorous companies trading at low multiples — the DCF is particularly powerful because the assumptions are easier to stress-test and the uncertainty range is narrower than for high-growth names. A small change in WACC or terminal growth shifts a value-stock DCF by 5-15%, not 50-100% as with hyper-growth tech.
The most important adjustment when valuing a cyclical or mature business is to normalize the starting free cash flow. Using peak-cycle earnings leads to overvaluation; using trough earnings leads to undervaluation. Average FCF over a full business cycle (7-10 years) to arrive at a mid-cycle figure that represents the business at a neutral point in the economic environment.
Apply conservative growth rates (0-5%), an appropriate WACC (7-10% for low-leverage industrials and consumer names), and a low terminal growth rate (1.5-2.5%). Then require a meaningful margin of safety — typically 25-40% below intrinsic value — before drawing any research conclusions. The discipline of the margin of safety is what separates value investing from "buying low and hoping."
The adjusted DCF formula for value stocks
The formula is unchanged, but the tuning matters:
Intrinsic Value = sum(t=1 to 10) [ FCF_t / (1 + WACC)^t ] + TV / (1 + WACC)^10
Where FCF_1 = normalized_FCF (mid-cycle average, not last 12 months)
And TV = FCF_10 x (1 + g_terminal) / (WACC - g_terminal)
Value-specific adjustments:
- Normalized FCF base. Use a 7-10 year average to span a full cycle. This is the single most important difference from a growth-stock DCF.
- Low Stage 1 growth. 0-5% per year. If a company has grown FCF at 2% for twenty years, projecting 8% in your model requires a very specific catalyst story.
- Moderate WACC. 7-10% for typical low-beta value names; use the WACC calculator to derive a ticker-specific number rather than guessing.
- Conservative terminal growth. 1.5-2.5% — below long-run inflation for declining industries.
- Share count compounding. Many value names buy back stock aggressively. Model declining share count to capture per-share value compounding.
- Sum-of-the-parts for conglomerates. Value each segment at its own discount rate; do not blend.
Worked example: Berkshire Hathaway (BRK.B)
Berkshire is the archetypal value-investor stock and a useful DCF case study. It is a conglomerate, so a sum-of-the-parts approach is more honest than a single DCF on aggregate cash flows — but for educational purposes, a consolidated value-style DCF shows the mechanics clearly. The numbers below are illustrative anchors only.
Starting inputs (illustrative). Assume BRK.B generates approximately $35B of normalized operating free cash flow on a trailing basis (excluding the lumpy contributions from investment portfolio realized gains, which are not operating cash flow). Shares outstanding sit near 2.16B (Class B equivalent). BRK has a beta well below the market — typically 0.8-0.9 — and very low financial leverage, justifying a WACC of 7-8%.
Stage 1 (years 1-10): low, steady growth. Model 4% FCF growth in year 1, tapering to 2.5% by year 10. This reflects realistic single-digit growth for a $900B-plus enterprise that cannot meaningfully outgrow the broad economy. Year-10 FCF lands near $46B in this scenario.
Terminal value. Apply a 2.0% terminal growth rate to reflect a mature, well-managed compounder. Terminal value = $46B x 1.02 / (0.075 - 0.02) = approximately $853B. Discount this back ten years at 7.5% WACC to roughly $414B in present-value terms.
Sum of present values. Discount each of the ten Stage-1 FCF figures back at 7.5% WACC and add the terminal present value. The example yields an operating-business enterprise value of approximately $670-700B. Then add the equity portfolio value at market (or 80% of market to reflect a tax-adjusted look-through value), subtract net debt, and divide by share count to obtain per-share intrinsic value.
Buyback compounding. Berkshire has repurchased shares opportunistically when management considers the stock to trade below intrinsic value. Even a modest 1% annual share-count reduction adds 10-12% to per-share intrinsic value over a decade.
Margin of safety. A 25-30% margin of safety relative to the calculated intrinsic value is the value-investor benchmark. If the stock trades at intrinsic value minus 30%, the model supports further research; if it trades at intrinsic value plus 10%, the model says wait.
Run the calculation
The calculator below pre-fills financials from any ticker. For value stocks, lower the WACC to 7-10%, set Stage 1 growth conservatively, normalize the FCF base, and apply a terminal growth of 1.5-2.5%. The margin-of-safety output is the figure you should focus on — it tells you whether the current market price provides the cushion required for a defensible research conclusion.